|
Market Closed -
London S.E.
11:20:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
Chart calendar Roche Holding AG
Upcoming events on Roche Holding AG
| 2026-10-22 | Earnings release - Q3 2026 | 03:00 |
Past events on Roche Holding AG
| 2026-09-28 | Information meeting | 04:30 |
| 2026-07-23 | Earnings presentation | 08:00 |
| 2026-07-23 | Earnings release - Q2 2026 | 01:00 |
| 2026-06-08 | Présentation aux Actionnaires / Analystes | 11:00 |
| 2026-05-12 | Analyst/Investor Day | 08:00 |
| 2026-04-23 | Sales and Revenue Release - Q1 2026 | 01:00 |
| 2026-04-22 | Présentation aux Actionnaires / Analystes | 11:00 |
| 2026-03-25 | Information meeting | 03:00 |
| 2026-03-10 | Annual General Meeting | 05:30 |
| 2026-03-09 | Information meeting | 12:00 |
| 2026-02-09 | Présentation aux Actionnaires / Analystes | 10:30 |
| 2026-01-29 | Earnings presentation | 07:30 |
| 2026-01-29 | Earnings release - Annual 2025 | 01:00 |
| 2025-12-11 | Présentation aux Actionnaires / Analystes | 10:30 |
| 2025-10-23 | Sales and Revenue Release - Q3 2025 | 01:00 |
| 2025-10-21 | Présentation aux Actionnaires / Analystes | 11:00 |
Past dividends on Roche Holding AG
| 2026-03-12 | Ex-dividend date - 9.8 CHF | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 58 716 59 502 -1.32% | 60 495 60 767 -0.45% | 61 516 61 677 -0.26% | 62 690 | 65 542 | 68 724 |
|
EBITDA Million CHF | Released Forecast Spread | 21 976 22 765 -3.46% | 23 538 23 173 1.57% | 24 608 24 868 -1.04% | 25 293 | 27 260 | 28 983 |
|
EBIT Million CHF | Released Forecast Spread | 19 240 19 957 -3.59% | 20 823 20 819 0.02% | 21 833 22 026 -0.88% | 22 820 | 24 404 | 25 968 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 14 079 17 867 -21.2% | 11 793 16 940 -30.38% | 16 973 18 559 -8.54% | 19 327 | 21 237 | 23 137 |
|
Net income Million CHF | Released Forecast Spread | 11 498 13 584 -15.35% | 8 277 12 984 -36.25% | 12 880 13 076 -1.5% | 14 492 | 16 324 | 17 557 |
|
EPS CHF | Released Forecast Spread | 14,3 17,0 -15.74% | 10,3 16,6 -38.08% | 16,0 16,7 -4.05% | 18,4 | 20,4 | 22,0 |
| Announcement Date | 01/02/24 | 30/01/25 | 29/01/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2026 S2 | 2027 Q1 | 2027 Q2 | 2027 S1 | 2027 Q3 | 2027 Q4 | 2027 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 15 511 15 341 1.11% | 30 647 30 647 -0% | 15 440 15 291 0.97% | 15 504 14 984 3.47% | 30 944 30 586 1.17% | 14 918 15 019 -0.67% | 15 654 15 206 2.95% | 30 572 30 352 0.72% | 14 722 14 903 -1.21% | 15 642 15 536 0.68% | 30 364 30 317 0.16% | 15 621 | 16 350 | 32 221 | 15 215 | 16 065 | 31 280 | 16 010 | 16 770 | 32 780 |
|
EBITDA Million CHF | Released Forecast Spread | 11 233 14 643 -23.29% | 15 318 | ||||||||||||||||||
|
EBIT Million CHF | Released Forecast Spread | 9 530 9 673 -1.48% | 12 010 11 495 4.48% | 9 823 9 963 -1.41% | 11 856 11 464 3.42% | 11 082 | |||||||||||||||
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 3 570 9 041 -60.51% | 7 385 8 151 -9.4% | 11 565 | |||||||||||||||||
|
Net income Million CHF | Released Forecast Spread | 2 019 6 736 -70.02% | 5 470 6 003 -8.88% | 8 573 | |||||||||||||||||
|
EPS CHF | Released Forecast Spread | 2,51 8,52 -70.54% | 6,81 7,49 -9.08% | 10,7 | |||||||||||||||||
| Announcement Date | 30/01/25 | 30/01/25 | 24/04/25 | 24/07/25 | 24/07/25 | 23/10/25 | 29/01/26 | 29/01/26 | 23/04/26 | 23/07/26 | 23/07/26 | - | - | - | - | - | - | - | - | - |
| 2026-10-08 |  | Ex-dividend date - 0.139 CNY | 00:00 |
| 2026-10-08 | | Sales and Revenue Release - Q3 2026 | 01:00 |
| 2026-10-09 | | Extraordinary General Meeting | 02:30 |
| 2026-10-12 | | Earnings presentation | 01:00 |
| 2026-10-13 | | Earnings release - Q3 2026 | 06:45 |
| 2026-10-13 | | Earnings presentation | 08:30 |
| 2026-10-13 | | Extraordinary General Meeting | 02:30 |
| 2026-10-13 | | Extraordinary General Meeting | |
| 2026-10-14 | | Extraordinary General Meeting | |
| 2026-10-14 | | Ex-dividend date - 1.02 CNY | 00:00 |
Past sector events for Roche Holding AG
| 2026-10-02 | | Ex-dividend date - 0.63 USD | 00:00 |
| 2026-10-02 | | Analyst/Investor Day | 01:00 |
| 2026-10-01 | | Information meeting | 08:00 |
| 2026-10-01 | | Board of Directors Meeting | 05:30 |
| 2026-10-01 | | Ex-dividend date - 0.99186 INR | 00:00 |
| 2026-10-01 | | Ex-dividend date - 0.99186 INR | 00:00 |
| 2026-09-30 | | Information meeting | |
| 2026-09-30 | | Annual General Meeting | 01:30 |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 01:30 |
| 2026-09-30 | | Extraordinary General Meeting | 02:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
- Calendar Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
